Blackstone acquired Clarus (Blackstone Life Sciences), a transaction completed in November 2018.
Clarus (Blackstone Life Sciences) operates in Life sciences investing, is based in Boston and San Francisco, USA.
Acquiring Clarus established Blackstone Life Sciences, a new platform able to invest across the life-cycle of companies and products, pairing Clarus's scientific and clinical-development expertise with Blackstone's scale to fund growth-stage investments and R&D collaborations with biopharmaceutical companies.
Advisory firms were not disclosed for this transaction.